Susquehanna International Group, LLP Xencor Inc Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Xencor Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 40,903 shares of XNCR stock, worth $459,340. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,903
Previous 16,510
147.75%
Holding current value
$459,340
Previous $332,000
182.83%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding XNCR
# of Institutions
198Shares Held
73.7MCall Options Held
1.7KPut Options Held
4.2K-
Black Rock Inc. New York, NY11.1MShares$125 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.98MShares$101 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.02MShares$90 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$69 Million6.6% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.04MShares$45.3 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $670M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...